about
Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver HomeostasisHerbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospectsHerbal adaptogens combined with protein fractions from bovine colostrum and hen egg yolk reduce liver TNF-α expression and protein carbonylation in Western diet feeding in ratsOxidative stress as a crucial factor in liver diseases.Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver.Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).Effect of melatonin versus vitamin D as antioxidant and Hepatoprotective agents in STZ-induced diabetic rats.Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches.Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease's Statin Therapy in Men.Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
P2860
Q26746997-B83564F9-C85B-477A-9A0C-0A488F553C1FQ26828615-A96273F4-48D9-4CB8-98BE-4FE2F6CA0D8DQ33597943-385C0035-AAB2-4C25-95BA-DC4B6628A285Q33845484-274573D0-CDAB-4E8D-B154-045A47195F33Q37286751-7EF58FFE-6E89-45A9-8756-C8B7FA37BE9AQ37438847-59668E7E-118D-415D-BA75-8A834AC0446DQ39044073-A7CBEC1E-A22B-47C8-B17A-7BA2582ED884Q42368061-11D6DA46-21AA-44EF-ACB6-C6D85BDBEF62Q50136712-EAE541FF-961D-491A-9D21-AFA910FF5A86Q55054498-6DE4A0F5-9A0A-4319-A2B9-327448D14329Q55078604-D23C6591-B1B1-4F19-87F3-EA92B3935596Q55709012-80BFA292-440C-4310-AD88-29FE0390749CQ58693431-155532AA-90F4-4C5D-BA94-D123C53735F0
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antioxidant therapy in nonalcoholic steatohepatitis.
@ast
Antioxidant therapy in nonalcoholic steatohepatitis.
@en
type
label
Antioxidant therapy in nonalcoholic steatohepatitis.
@ast
Antioxidant therapy in nonalcoholic steatohepatitis.
@en
prefLabel
Antioxidant therapy in nonalcoholic steatohepatitis.
@ast
Antioxidant therapy in nonalcoholic steatohepatitis.
@en
P2093
P2860
P356
P1476
Antioxidant therapy in nonalcoholic steatohepatitis.
@en
P2093
Mamatha Bhat
Marc Deschenes
Peter Ghali
Philip Wong
Said A Al-Busafi
P2860
P304
P356
10.1155/2012/947575
P577
2012-11-22T00:00:00Z